Paul Sagan | Investor Relations |
Glenn Mattes | President & Chief Executive Officer |
Dale Christensen | Director, Clinical Development |
Kirk Coleman | Chief Financial Officer |
Bill Williams | Professor, University of Texas, Austin |
Chris Cano | Chief Operating Officer |
Jonathan Aschoff | ROTH Capital Partners |
Boobalan Pachaiyappan | H.C. Wainwright |
Mayank Mamtani | B. Riley Securities |
Daniel Carlson | TW Research Group |
Bill Morrison | National Securities |
Good afternoon ladies and gentlemen and welcome to the TFF Pharmaceuticals’ 2020 Financial Results Conference Call.
As a reminder, this conference is being recorded. I would now turn the call over to your host, Mr. Paul Sagan of TFF Pharmaceuticals Investor Relations.
You may begin your conference.